UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in VKTX — Viking Therapeutics, Inc.
CIK 861177
NEW YORK, NY
Position in VKTX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$8,261,707
-$119,115 QoQ
Shares Held
253,894
+6.6% QoQ
Ownership
0.219%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 24.470054432164602.ToString("F0")%
Shared 0.ToString("F0")%
None 75.5299455678354.ToString("F0")%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. VKTX ranks #47 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in VKTX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,261,707 | 253,894 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $8,380,822 | 238,227 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $6,406,167 | 243,766 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,490,990 | 509,094 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $11,351,170 | 470,028 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $18,644,474 | 463,332 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $29,897,763 | 472,244 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $25,412,672 | 479,394 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $29,158,216 | 355,588 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $8,841,852 | 475,113 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,299,153 | 478,695 | Shares | Defined | 2023-11-13 | |
| 2022-03-31 | $333,477 | 111,159 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $511,329 | 111,159 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $698,076 | 111,159 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $774,075 | 129,228 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $634,016 | 100,240 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $724,243 | 128,640 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $419,853 | 72,140 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $520,128 | 72,140 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $405,582 | 86,663 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||